RABGAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.970800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.343800E-01
Normal-vs-Stage2
8.076200E-01
Normal-vs-Stage3
8.148200E-02
Normal-vs-Stage4
9.378000E-01
Stage1-vs-Stage2
8.345400E-01
Stage1-vs-Stage3
1.381410E-01
Stage1-vs-Stage4
6.043200E-01
Stage2-vs-Stage3
1.052640E-01
Stage2-vs-Stage4
7.094000E-01
Stage3-vs-Stage4
1.202250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.946000E-01
Normal-vs-AfricanAmerican
5.174200E-01
Normal-vs-Asian
8.959000E-01
Caucasian-vs-AfricanAmerican
7.179600E-01
Caucasian-vs-Asian
8.331200E-01
AfricanAmerican-vs-Asian
6.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.606200E-01
Normal-vs-Female
8.300400E-01
Male-vs-Female
6.934600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.983000E-01
Normal-vs-Age(41-60Yrs)
8.396200E-01
Normal-vs-Age(61-80Yrs)
6.514600E-01
Normal-vs-Age(81-100Yrs)
3.398000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.208800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.705400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.962600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.208200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.737600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.172200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.555800E-01
Normal-vs-Daily Drinker
8.197400E-01
Normal-vs-Weekly Drinker
5.832600E-01
Normal-vs-Occasional Drinker
9.697400E-01
Normal-vs-Social Drinker
6.254000E-01
Non Drinker-vs-Daily Drinker
2.109600E-01
Non Drinker-vs-Weekly Drinker
5.194800E-01
Non Drinker-vs-Occasional Drinker
5.561800E-02
Non Drinker-vs-Social Drinker
3.272400E-02
Daily Drinker-vs-Weekly Drinker
6.475600E-01
Daily Drinker-vs-Occasional Drinker
5.954200E-01
Daily Drinker-vs-Social Drinker
1.758400E-01
Weekly Drinker-vs-Occasional Drinker
3.013000E-01
Weekly Drinker-vs-Social Drinker
1.133580E-01
Occasional Drinker-vs-Social Drinker
3.475000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.177700E-02
Normal-vs-Grade 2
1.158080E-02
Normal-vs-Grade 3
8.143400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.277400E-01
Grade 1-vs-Grade 3
8.061500E-02
Grade 1-vs-Grade 4
6.177700E-02
Grade 2-vs-Grade 3
3.364400E-01
Grade 2-vs-Grade 4
1.158080E-02
Grade 3-vs-Grade 4
8.143400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.121400E-01
Normal-vs-NonDiabetic
8.427800E-01
Diabetic-vs-NonDiabetic
2.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.997200E-01
Normal-vs-NoPancreatitis
7.416800E-01
Pancreatitis-vs-NoPancreatitis
1.986980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.848400E-01
Normal-vs-N1
7.965800E-01
N0-vs-N1
8.945800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.795000E-01
Normal-vs-TP53-NonMutant
8.941400E-01
TP53-Mutant-vs-TP53-NonMutant
3.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
